# BIOE (Bio Essence Corp.) - SEC EDGAR Financial Statements

> Bio Essence Corp. reported $3.03M in revenue and net income of $1.35M for the trailing twelve months ended September 30, 2026 (up 85.0% year over year), with a 68.4% gross margin and a 45.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/BIOE
- Markdown: https://convexityos.com/fundamentals/BIOE.md
- SEC CIK: 0001723059
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:04 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001723059&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $3.03M | +85.0% YoY |
| Operating Income | TTM | $1.37M | 45.1% margin |
| Net Income | TTM | $1.35M | 44.7% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $202K | Total debt: $1.56M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.90M | $324K | $552K | $622K | $888K | $959K |
| Cost of Revenue | $469K | $107K | $274K | $293K | $590K | $731K |
| **Gross Profit** | $1.43M | $217K | $277K | $328K | $298K | $227K |
| Selling, General & Admin | $528K | -- | $438K | $839K | $1.15M | $1.06M |
| Total Operating Expenses | $528K | $677K | $346K | $839K | $1.16M | $1.06M |
| **Operating Income** | $900K | -$459K | -$346K | -$511K | -$858K | -$833K |
| **EBITDA** | $900K | -$459K | -$341K | -$497K | -$822K | -$799K |
| Interest Expense | $2.2K | $2.2K | $17K | $14K | $39K | $42K |
| Income Before Tax | $897K | -$1.56M | -$403K | -$525K | -$644K | -$593K |
| Income Tax Expense | $800 | $800 | $1.6K | $2.5K | $3.3K | $3.3K |
| **Net Income** | $896K | -$1.31M | -$972K | -$810K | -$648K | -$596K |
| Basic EPS | -- | -$0.03 | -$0.03 | -$0.02 | -$0.02 | -$0.02 |
| **Diluted EPS** | -- | -$0.03 | -$0.03 | -$0.02 | -$0.02 | -$0.02 |
| Basic Shares Outstanding | 38.0M | 38.0M | 34.0M | 33.0M | 33.0M | 33.0M |
| Diluted Shares Outstanding | 38.0M | 38.0M | 36.0M | 33.0M | 33.0M | 33.0M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $253K | $795K | $501K | $1.48M | $137K | $259K | $22K | -- |
| Cost of Revenue | $114K | $324K | $181K | $336K | $41K | $90K | $1.6K | -- |
| **Gross Profit** | $139K | $470K | $319K | $1.14M | $96K | $169K | $21K | -- |
| Selling, General & Admin | $298K | $191K | $104K | $114K | $82K | $107K | $226K | -- |
| Total Operating Expenses | $298K | $191K | $104K | $114K | $82K | $107K | $226K | $103K |
| **Operating Income** | -$159K | $279K | $216K | $1.03M | $14K | $61K | -$205K | $3.9K |
| **EBITDA** | $16K | $383K | $216K | $1.03M | $14K | $61K | -$205K | $3.9K |
| Interest Expense | -$3.5K | -$2.3K | $542 | $540 | $556 | $547 | $543 | $536 |
| Income Before Tax | -$156K | $280K | $215K | $1.03M | $13K | $61K | -$206K | -$28K |
| Income Tax Expense | -$5.2K | $10K | $9.8K | -- | -- | $800 | -- | -- |
| **Net Income** | -$150K | $270K | $205K | $1.03M | $13K | $60K | -$206K | -$28K |
| Basic EPS | -- | -- | -- | -- | -- | $0.00 | -$0.01 | -- |
| **Diluted EPS** | -- | -- | -- | -- | -- | $0.00 | -$0.01 | -- |
| Basic Shares Outstanding | 54.0M | 50.9M | 45.0M | -- | 38.0M | 38.0M | 38.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $1.4K | $114 | $6.3K | $303 | $5.3K |
| **Cash & Short-Term Investments** | -- | $1.4K | $114 | $6.3K | $303 | $5.3K |
| Accounts Receivable, Net | $23K | $5.1K | $35K | $5.6K | $17K | $45K |
| Inventory | -- | -- | $143K | $181K | $213K | $272K |
| **Total Current Assets** | $422K | $281K | $300K | $204K | $262K | $330K |
| Property, Plant & Equipment, Net | -- | -- | $3.7K | $246K | $181K | $92K |
| Intangible Assets | $97 | $332 | $567 | $802 | $1.0K | $7.4K |
| Other Non-Current Assets | -- | $332 | $1.48M | -- | -- | -- |
| **Total Non-Current Assets** | $97 | $332 | $1.56M | $1.34M | $1.44M | $1.52M |
| **Total Assets** | $422K | $281K | $2.76M | $1.55M | $1.70M | $1.85M |
| Accounts Payable | $48K | $18K | $12K | $50K | $63K | $50K |
| **Total Current Liabilities** | $2.44M | $2.80M | $2.45M | $3.56M | $2.76M | $1.89M |
| Long-Term Debt | $57K | $56K | -- | -- | -- | -- |
| Other Non-Current Liabilities | -- | $447K | $992K | -- | -- | -- |
| **Total Non-Current Liabilities** | $56K | $447K | $1.14M | $1.23M | $1.37M | $1.73M |
| **Total Liabilities** | $2.50M | $3.25M | $4.42M | $4.79M | $4.13M | $3.63M |
| **Total Debt (incl. Leases)** | $1.56M | $1.56M | $1.44M | $1.12M | $2.41M | $2.73M |
| Common Stock | $3.8K | $3.8K | $3.8K | $3.3K | $3.3K | $3.3K |
| Retained Earnings | -$9.55M | -$10.45M | -$9.14M | -$8.17M | -$7.36M | -$6.71M |
| **Total Stockholders' Equity** | -$2.07M | -$2.97M | -$1.66M | -$3.24M | -$2.43M | -$1.78M |
| Total Equity | -$2.07M | -$2.97M | -$1.66M | -$3.24M | -$2.43M | -$1.78M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $202K | $675 | $36K | -- | $29K | -- | -- | $1.4K |
| **Cash & Short-Term Investments** | $202K | $675 | $36K | -- | $29K | -- | -- | $1.4K |
| Accounts Receivable, Net | -- | -- | $5.3K | $23K | $5.0K | $5.0K | $8.2K | $5.1K |
| **Total Current Assets** | $279K | $607K | $789K | $422K | $184K | $112K | $365K | $281K |
| Intangible Assets | $3.22M | $3.40M | $38 | $97 | $156 | $215 | $274 | $332 |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $274 | $332 |
| **Total Non-Current Assets** | $3.72M | $3.40M | $38 | $97 | $156 | $215 | $274 | $332 |
| **Total Assets** | $4.00M | $4.00M | $789K | $422K | $185K | $113K | $366K | $281K |
| Accounts Payable | -- | -- | $3.1K | $48K | $11K | $11K | $24K | $18K |
| **Total Current Liabilities** | $1.65M | $1.61M | $2.16M | $2.44M | $3.23M | $3.07M | $3.24M | $2.80M |
| Long-Term Debt | $57K | $57K | $57K | $57K | $58K | $58K | $56K | $56K |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | $302K | $447K |
| **Total Non-Current Liabilities** | $55K | $55K | $56K | $56K | $56K | $156K | $302K | $447K |
| **Total Liabilities** | $1.71M | $1.66M | $2.22M | $2.50M | $3.29M | $3.23M | $3.54M | $3.25M |
| **Total Debt (incl. Leases)** | $1.56M | $1.56M | $1.57M | $1.56M | $1.55M | $1.55M | $1.53M | $1.56M |
| Common Stock | $5.6K | $5.4K | $4.7K | $3.8K | $3.8K | $3.8K | $3.8K | $3.8K |
| Retained Earnings | -$9.23M | -$9.08M | -$9.35M | -$9.55M | -$10.58M | -$10.60M | -$10.66M | -$10.45M |
| **Total Stockholders' Equity** | $2.29M | $2.34M | -$1.43M | -$2.07M | -$3.10M | -$3.11M | -$3.17M | -$2.97M |
| Total Equity | $2.29M | $2.34M | -$1.43M | -$2.07M | -$3.10M | -$3.11M | -$3.17M | -$2.97M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | $896K | -$1.31M | -$972K | -$810K | -$648K | -$596K |
| Depreciation & Amortization | $235 | $911 | $4.8K | $15K | $36K | $33K |
| Stock-Based Compensation | -- | -- | -- | -- | -- | $8.9K |
| Change in Receivables | -$18K | -$5.1K | -$5.8K | $1.4K | $20K | -$24K |
| Change in Inventory | -- | -- | -$10K | $35K | $59K | $257K |
| Change in Payables | $30K | $5.3K | -$10K | -$15K | $12K | -$25K |
| **Operating Cash Flow** | $1.57M | $624K | -$1.03M | -$703K | -$1.29M | -$733K |
| Capital Expenditure | -- | -- | -$3.6K | -$3.7K | -$119K | -$7.4K |
| **Free Cash Flow** | -- | -- | -$1.03M | -$707K | -$1.41M | -$740K |
| Acquisitions, Net | -- | -$114 | -- | -- | -- | -- |
| **Investing Cash Flow** | -- | -$114 | -$91K | -$59K | -$117K | -$7.4K |
| Common Stock Issued | -- | -- | -- | -- | -- | -$100K |
| **Financing Cash Flow** | -$1.57M | -$622K | $1.11M | $768K | $1.41M | $729K |
| **Net Change in Cash** | -$1.4K | $1.3K | -$6.1K | $6.0K | -$5.0K | -$11K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$150K | $270K | $205K | $1.03M | $13K | $60K | -$206K | -$28K |
| Depreciation & Amortization | $175K | $104K | $59 | $59 | $58 | $59 | $59 | $58 |
| Change in Receivables | $0 | $5.3K | $18K | -$18K | $0 | $3.2K | -$3.1K | -- |
| Change in Payables | $0 | -$3.1K | -$45K | $37K | -$85 | -$13K | $6.4K | -$14K |
| **Operating Cash Flow** | -$369K | $60K | -$412K | $1.24M | $187K | $168K | -$26K | $423K |
| Common Stock Issued | $100K | $0 | $440K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $100K | -$10K | $448K | -$1.27M | -$158K | -$168K | $25K | -$452K |
| **Net Change in Cash** | $201K | -$36K | $36K | -$29K | $29K | $0 | -$1.4K | -$29K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 75.3% | 67.0% | 50.3% | 52.8% | 33.6% | 23.7% |
| **Operating Margin** | 47.4% | -141.8% | -62.7% | -82.2% | -96.6% | -86.8% |
| **Net Profit Margin** | 47.2% | -404.0% | -176.2% | -130.3% | -72.9% | -62.2% |
| Return on Assets (ROA) | 212.1% | -465.7% | -35.2% | -52.3% | -38.1% | -32.3% |
| Current Ratio | 0.17x | 0.10x | 0.12x | 0.06x | 0.10x | 0.17x |
| Quick Ratio | -- | 0.00x | 0.06x | 0.01x | 0.02x | 0.03x |
| **Revenue Growth (YoY)** | +485.8% | -41.3% | -11.3% | -30.0% | -7.4% | -- |
| Gross Profit Growth (YoY) | +558.0% | -21.8% | -15.5% | +10.1% | +31.3% | -- |
| Operating Cash Flow Growth (YoY) | +151.6% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +72.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 68.4% | 69.7% | 72.7% | 75.3% | -- | -- | -- | -- |
| **Operating Margin** | 45.1% | 52.9% | 55.6% | 47.4% | -- | -- | -- | -- |
| **Net Profit Margin** | 44.7% | 52.1% | 55.0% | 47.2% | -- | -- | -- | -- |
| Return on Equity (ROE) | 59.1% | 64.8% | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | 33.8% | 37.9% | 165.7% | 212.1% | -87.0% | -1218.3% | -450.8% | -465.7% |
| Current Ratio | 0.17x | 0.38x | 0.37x | 0.17x | 0.06x | 0.04x | 0.11x | 0.10x |
| Quick Ratio | 0.12x | 0.00x | 0.02x | -- | 0.01x | -- | -- | 0.00x |
| Debt to Equity | 0.68x | 0.66x | -- | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | +85.0% | +206.7% | +2155.8% | -- | +1.6% | +521.5% | -- | -- |
| Gross Profit Growth (YoY) | +45.3% | +178.8% | +1451.2% | -- | +18.2% | +477.8% | -- | -- |
| Operating Income Growth (YoY) | -1216.4% | +356.2% | -- | +26629.7% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -1257.5% | +351.2% | -- | -- | -- | -- | -253.6% | -- |
| Operating Cash Flow Growth (YoY) | -297.3% | -64.5% | -- | +193.3% | -47.6% | +998.7% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
